Medicis Declares Cash Dividend.

Publication: Business Wire

Bookmark this article Print this article Link to this article Email this article Digg It! Add to del.icio.us RSS

COPYRIGHT 2003 Business Wire

Business Editors/Health/Medical Writers

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Sept. 19, 2003

Medicis (NYSE:MRX) today announced that its Board of Directors declared a quarter-end cash dividend of $0.05 per issued and outstanding share of its Common Stock payable on October 31, 2003, to stockholders of record at the close of business on October 1, 2003.

Medicis is the leading independent specialty pharmaceutical company in the United States focusing primarily on the treatment of dermatological, pediatric and podiatric conditions. Medicis has leading prescription products in a number of therapeutic categories, including acne, asthma, eczema, fungal infections, hyperpigmentation, photoaging, psoriasis, rosacea, seborrheic dermatitis and skin and...

Read the full article for free courtesy of your local library.